Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia

Figure 1 Comparison of the mental symptoms and the cognitive function between the groups. A: Comparison of the mental symptoms; B: Comparison of the cognitive function. MoCA: Montreal Cognitive Assessment; PANSS: Positive and Negative Syndrome Scale. ^aP < 0.05.

Figure 2 Comparison of the quality of life between the groups. A: Comparison of the quality of life between the two groups from the psychosocial society aspect; B: Comparison of the quality of life between the two groups from the motivation and energy aspect; C: Comparison of the quality of life between the two groups from the aspect of symptoms and adverse reactions. ^aP < 0.05; ^bP < 0.01.